Feifei Gu

516 total citations
26 papers, 261 citations indexed

About

Feifei Gu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Feifei Gu has authored 26 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Feifei Gu's work include Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Immune Cell Function and Interaction (3 papers). Feifei Gu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Immune Cell Function and Interaction (3 papers). Feifei Gu collaborates with scholars based in China. Feifei Gu's co-authors include Li Liu, Jinyan Liang, Kai Zhang, Yulan Zeng, Yuanliang Huang, Xiaohua Hong, Yangyang Liu, Qifan Yang, Yangyang Liu and Yue Hu and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Frontiers in Immunology.

In The Last Decade

Feifei Gu

26 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feifei Gu China 11 88 71 69 63 62 26 261
Jinjin Feng China 9 52 0.6× 136 1.9× 22 0.3× 61 1.0× 37 0.6× 23 311
Simona Ruxandra Volovăț Romania 11 106 1.2× 157 2.2× 36 0.5× 62 1.0× 95 1.5× 41 372
Yihe Liu China 9 60 0.7× 93 1.3× 35 0.5× 32 0.5× 64 1.0× 33 350
Yuming Jia China 11 91 1.0× 170 2.4× 29 0.4× 57 0.9× 71 1.1× 37 313
Chenbei Li China 8 37 0.4× 112 1.6× 31 0.4× 30 0.5× 47 0.8× 23 265
Yi Yan China 14 60 0.7× 244 3.4× 40 0.6× 22 0.3× 181 2.9× 48 561
Rui Bergantim Portugal 10 117 1.3× 319 4.5× 39 0.6× 23 0.4× 139 2.2× 33 465
Xiaopeng Guo China 11 45 0.5× 82 1.2× 58 0.8× 41 0.7× 55 0.9× 31 337
Karen Chagin United States 9 181 2.1× 58 0.8× 105 1.5× 67 1.1× 6 0.1× 17 345

Countries citing papers authored by Feifei Gu

Since Specialization
Citations

This map shows the geographic impact of Feifei Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Gu more than expected).

Fields of papers citing papers by Feifei Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feifei Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Gu. The network helps show where Feifei Gu may publish in the future.

Co-authorship network of co-authors of Feifei Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Feifei Gu. A scholar is included among the top collaborators of Feifei Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feifei Gu. Feifei Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Ling, Tingting Pan, Ziyun Shen, et al.. (2023). The ICU-CARB score: a novel clinical scoring system to predict carbapenem-resistant gram-negative bacteria carriage in critically ill patients upon ICU admission. Antimicrobial Resistance and Infection Control. 12(1). 118–118. 3 indexed citations
2.
Li, Chang, Chen Tian, Yulan Zeng, et al.. (2022). Integrated Analysis of MATH-Based Subtypes Reveals a Novel Screening Strategy for Early-Stage Lung Adenocarcinoma. Frontiers in Cell and Developmental Biology. 10. 769711–769711. 4 indexed citations
3.
Li, Chang, Chen Tian, Yulan Zeng, et al.. (2022). Machine learning and bioinformatics analysis revealed classification and potential treatment strategy in stage 3–4 NSCLC patients. BMC Medical Genomics. 15(1). 33–33. 4 indexed citations
4.
Li, Minghua, Qingxiu Li, Shijie Zhang, et al.. (2022). Magnetic properties and microstructural analyses of Pt/Co/Gd2O3 films. Vacuum. 205. 111410–111410. 6 indexed citations
5.
Gu, Feifei, et al.. (2022). The osteogenesis effect of rhBMP2-loaded calcium phosphate cements in repairing dental extraction sockets.. PubMed. 14(10). 7172–7177. 1 indexed citations
6.
Liu, Yuting, Juanjuan Wang, Jingjing Wu, et al.. (2021). The Efficacy of First-Generation EGFR-TKI Combined With Brain Radiotherapy as the First-Line Treatment for Lung Adenocarcinoma Patients With Brain Metastases and EGFR Sensitive Mutations: A Retrospective study. Technology in Cancer Research & Treatment. 20. 1080265467–1080265467. 10 indexed citations
7.
Li, Chang, Chen Tian, Yangyang Liu, et al.. (2021). Comprehensive Profiling Reveals Distinct Microenvironment and Metabolism Characterization of Lung Adenocarcinoma. Frontiers in Genetics. 12. 619821–619821. 3 indexed citations
8.
Tian, Chen, Yulan Zeng, Jinyan Liang, et al.. (2021). Identification of CXCL13/CXCR5 axis’s crucial and complex effect in human lung adenocarcinoma. International Immunopharmacology. 94. 107416–107416. 10 indexed citations
9.
Gu, Feifei, Jingjing Wu, Yangyang Liu, et al.. (2020). Human inflammatory dendritic cells in malignant pleural effusions induce Th1 cell differentiation. Cancer Immunology Immunotherapy. 69(5). 779–788. 14 indexed citations
10.
Wu, Di, Yangyang Liu, Xiaoting Li, et al.. (2020). Identification of Clonal Neoantigens Derived From Driver Mutations in an EGFR-Mutated Lung Cancer Patient Benefitting From Anti-PD-1. Frontiers in Immunology. 11. 1366–1366. 15 indexed citations
11.
Liu, Yuting, Jingjing Wu, Kai Zhang, et al.. (2019). Application of metabolomics by UHPLC-MS/MS in diagnostics and biomarker discovery of non-small cell lung cancer. Translational Cancer Research. 8(6). 2371–2379. 1 indexed citations
12.
Liang, Jinyan, Chen Tian, Yulan Zeng, et al.. (2019). FOXA1+ regulatory T cells: A novel T cell subset that suppresses antitumor immunity in lung cancer. Biochemical and Biophysical Research Communications. 514(1). 308–315. 18 indexed citations
13.
Liang, Jinyan, Qifan Yang, Yulan Zeng, et al.. (2019). Clinical value of MLH1-negative circulating tumor cells in lung cancer patients. Medicine. 98(25). e15721–e15721. 3 indexed citations
14.
Liu, Yuting, Jingjing Wu, Kai Zhang, et al.. (2019). Application of metabolomics by UHPLC-MS/MS in diagnostics and biomarker discovery of non-small cell lung cancer. Translational Cancer Research. 8(6). 2371–2379. 8 indexed citations
15.
Liang, Jinyan, Fan Tong, Feifei Gu, et al.. (2017). Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma. Medicine. 96(21). e6985–e6985. 1 indexed citations
16.
Liu, Yangyang, Feifei Gu, Jinyan Liang, et al.. (2017). The efficacy and toxicity profile of metronomic chemotherapy for metastatic breast cancer: A meta-analysis. PLoS ONE. 12(3). e0173693–e0173693. 33 indexed citations
17.
Huang, Yuanliang, et al.. (2017). rhBMP2-loaded calcium phosphate cements combined with allogenic bone marrow mesenchymal stem cells for bone formation. Biomedicine & Pharmacotherapy. 92. 536–543. 15 indexed citations
18.
Gu, Feifei, et al.. (2016). The effects of icaritin on the proliferation and osteogenic differentiation of rat bone marrow stromal cells. 32(4). 470. 1 indexed citations
19.
Han, Junxing, Feifei Gu, & Yuchao Li. (2016). N‐Doped Sub‐3 nm Co Nanoparticles as Highly Efficient and Durable Aerobic Oxidative Coupling Catalysts. Chemistry - An Asian Journal. 11(18). 2594–2601. 11 indexed citations
20.
Reza, Hassan, Feifei Gu, & Bahram Shafai. (2010). Toward Model Based Testing: Combining AADLS with High Level Petri Nets.. Software Engineering Research and Practice. 122(9). 619–623. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinjin Feng Breakdown of academic impact, for papers by Simona Ruxandra Volovăț Breakdown of academic impact, for papers by Yihe Liu Breakdown of academic impact, for papers by Yuming Jia Breakdown of academic impact, for papers by Chenbei Li Breakdown of academic impact, for papers by Yi Yan Breakdown of academic impact, for papers by Rui Bergantim Breakdown of academic impact, for papers by Xiaopeng Guo Breakdown of academic impact, for papers by Karen Chagin
Rankless by CCL
2026